review of glp-1 Cardiovascular Effects and Tolerability Receptor Agonists: A Systematic and Meta-Analysis of 99,599 Patients The New - GLP-1 receptor
Description
Calocurb is not indicated for patients with type 1 diabetes mellitus
I tested Willow and Hers for GLP-1 weight loss meds
19, 2024Announcing the 2024 Lasker Awards in Basic Research, Clinical Research, and Public Service
For drugs with a narrow therapeutic index, other factors need to be monitored closely, including plasma drug levels, patients clinical outcomes, and laboratory markers
Optimizes carbohydrate utilization for energy and recovery
By May 2025, GLP-1s accounted for 52% of all diabetes prescription volume, up from just 18% in 2020
